Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

620 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Outcomes of Cardiac Resynchronization Therapy by New York Heart Association Class: A Patient-Level Meta-Analysis.
Shivakumar N, Friedman DJ, Fudim M, Abraham WT, Cleland JGF, Curtis AB, Gold MR, Kutyifa V, Linde C, Young J, Tang A, Olivas-Martinez A, Inoue LYT, Sanders GD, Al-Khatib SM. Shivakumar N, et al. Among authors: abraham wt. J Am Heart Assoc. 2024 Aug 6;13(15):e031785. doi: 10.1161/JAHA.123.031785. Epub 2024 Jul 31. J Am Heart Assoc. 2024. PMID: 39082424 Free article.
Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial.
Young JB, Abraham WT, Smith AL, Leon AR, Lieberman R, Wilkoff B, Canby RC, Schroeder JS, Liem LB, Hall S, Wheelan K; Multicenter InSync ICD Randomized Clinical Evaluation (MIRACLE ICD) Trial Investigators. Young JB, et al. Among authors: abraham wt. JAMA. 2003 May 28;289(20):2685-94. doi: 10.1001/jama.289.20.2685. JAMA. 2003. PMID: 12771115 Clinical Trial.
Effects of cardiac resynchronization on disease progression in patients with left ventricular systolic dysfunction, an indication for an implantable cardioverter-defibrillator, and mildly symptomatic chronic heart failure.
Abraham WT, Young JB, León AR, Adler S, Bank AJ, Hall SA, Lieberman R, Liem LB, O'Connell JB, Schroeder JS, Wheelan KR; Multicenter InSync ICD II Study Group. Abraham WT, et al. Circulation. 2004 Nov 2;110(18):2864-8. doi: 10.1161/01.CIR.0000146336.92331.D1. Epub 2004 Oct 25. Circulation. 2004. PMID: 15505095 Clinical Trial.
Safety of transvenous cardiac resynchronization system implantation in patients with chronic heart failure: combined results of over 2,000 patients from a multicenter study program.
León AR, Abraham WT, Curtis AB, Daubert JP, Fisher WG, Gurley J, Hayes DL, Lieberman R, Petersen-Stejskal S, Wheelan K; MIRACLE Study Program. León AR, et al. Among authors: abraham wt. J Am Coll Cardiol. 2005 Dec 20;46(12):2348-56. doi: 10.1016/j.jacc.2005.08.031. J Am Coll Cardiol. 2005. PMID: 16360070 Free article.
Rationale and design of a randomized controlled trial to assess the safety and efficacy of cardiac resynchronization therapy in patients with asymptomatic left ventricular dysfunction with previous symptoms or mild heart failure--the REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction (REVERSE) study.
Linde C, Gold M, Abraham WT, Daubert JC; REVERSE Study Group. Linde C, et al. Among authors: abraham wt. Am Heart J. 2006 Feb;151(2):288-94. doi: 10.1016/j.ahj.2005.03.002. Am Heart J. 2006. PMID: 16442890
Clinical predictors and timing of New York Heart Association class improvement with cardiac resynchronization therapy in patients with advanced chronic heart failure: results from the Multicenter InSync Randomized Clinical Evaluation (MIRACLE) and Multicenter InSync ICD Randomized Clinical Evaluation (MIRACLE-ICD) trials.
Pires LA, Abraham WT, Young JB, Johnson KM; MIRACLE and MIRACLE-ICD Investigators. Pires LA, et al. Among authors: abraham wt. Am Heart J. 2006 Apr;151(4):837-43. doi: 10.1016/j.ahj.2005.06.024. Am Heart J. 2006. PMID: 16569543
620 results